TY - JOUR T1 - Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo. JO - Clin Cancer Res UR - http://eprints.whiterose.ac.uk/110818/ PY - 2014/06/01 AU - Ottewell PD AU - Wang N AU - Brown HK AU - Reeves KJ AU - Fowles CA AU - Croucher PI AU - Eaton CL AU - Holen I ED - DO - DOI: 10.1158/1078-0432.CCR-13-1246 VL - 20 IS - 11 SP - 2922 EP - 2932 Y2 - 2025/04/12 ER -